N-glycans and metastasis in galectin-3 transgenic mice

被引:14
|
作者
More, Shyam K. [1 ]
Srinivasan, Nithya [1 ]
Budnar, Srikanth [2 ]
Bane, Sanjay M. [1 ]
Upadhya, Archana [3 ]
Thorat, Rahul A. [1 ]
Ingle, Arvind D. [1 ]
Chiplunkar, Shubhada V. [1 ]
Kalraiya, Rajiv D. [1 ]
机构
[1] Tata Mem Hosp, ACTREC, Kharghar 410210, Navi Mumbai, India
[2] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia
[3] SVKMs NMIMS, SPP Sch Pharm & Technol Management, Bombay, Maharashtra, India
关键词
Galectin-3; Organ specific metastasis; Galectin-3 transgenic mice; PHASEOLUS-VULGARIS; CANCER METASTASIS; TUMOR-METASTASIS; MELANOMA-CELLS; OLIGOSACCHARIDES; EXPRESSION; RECEPTORS; ACETYLGLUCOSAMINYLTRANSFERASE; GLYCOSYLATION; PROGRESSION;
D O I
10.1016/j.bbrc.2015.03.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Poly-N-acetyl-lactosamine (polyLacNAc) on N-glycans facilitate lung specific metastasis of melanoma cells by serving as high affinity ligands for galectin-3, expressed in highest amounts in the lungs, on almost all its tissue compartments including on the surface of vascular endothelium. PolyLacNAc not only aids in initial arrest on the organ endothelium but in all the events of extravasation. Inhibition of polyLacNAc synthesis, or competitive inhibition of its interaction with galectin-3 all inhibited these processes and experimental metastasis. Transgenic galectin-3 mice, viz., gal-3(+/+) (wild type), gal-3(+/-) (hemizygous) and gal-(3-/-) (null) have been used to prove that galectin-3/polyLacNAc interactions are indeed critical for lung specific metastasis. Gal-3(+/-) mice which showed <50% expression of galectin-3 on the lungs also showed proportionate decrease in the number of B16F10 melanoma metastatic colonies affirming that galectin-3 and polyLacNAc interactions are indeed key determinants of lung metastasis. However, surprisingly, the number and size of metastatic colonies in gal-3(-/-) mice was very similar as that seen in gal-3(+/+) mice. The levels of lactose binding lectins on the lungs and the transcripts of other galectins (galectin-1, -8 and -9) which are expressed on lungs and have similar sugar binding specificities as galectins-3, remain unchanged in gal-3(+/+) and gal-3(-/-) mice. Further, inhibition of N-glycosylation with Swainsonine (SW) which drastically reduces metastasis of Bl6F10 cells in gal-3(+/+) mice, did not affect lung metastasis when assessed in gal-3(-/-) mice. Together, these results rule out the possibility of some other galectin taking over the function of galectin-3 in gal-3(-/-) mice. Chimeric mice generated to assess if absence of any effect on metastasis is due to compromised tumor immunity by replacing bone marrow of gal-3(-/-) mice with that from gal-3(+/+) mice, also failed to impact melanoma metastasis. As galectin-3 regulates several immune functions including maturation of different immune cells, compromised tumor immunity could be the major determinant of melanoma metastasis in gal-3(-/-) mice and warrants thorough investigation. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:302 / 307
页数:6
相关论文
共 50 条
  • [21] Regulation of galectin-3-induced apoptosis of Jurkat cells by both O-glycans and N-glycans on CD45
    Xue, Jing
    Gao, Xiqiang
    Fu, Chunyan
    Cong, Zhe
    Jiang, Hong
    Wang, Wei
    Chen, Ting
    Wei, Qiang
    Qin, Chuan
    FEBS LETTERS, 2013, 587 (24): : 3986 - 3994
  • [22] CIRCULATING GALECTIN-3: METASTASIS PROMOTER AND THERAPEUTIC TARGET
    Yu, Lu-Gang
    ANTICANCER RESEARCH, 2015, 35 (07) : 4295 - 4295
  • [23] Galectin-3 as a Potential Target to Prevent Cancer Metastasis
    Ahmed, Hafiz
    AlSadek, Dina M. M.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2015, 9 : 113 - 121
  • [24] Autoimmune Disorders in Galectin-3 Deficient Mice
    Volarevic, Vladislav
    Lukic, Miodrag L.
    GALECTINS AND DISEASE IMPLICATIONS FOR TARGETED THERAPEUTICS, 2012, 1115 : 359 - 376
  • [25] Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells
    Patnaik, SK
    Potvin, B
    Carlsson, S
    Sturm, D
    Leffler, H
    Stanley, P
    GLYCOBIOLOGY, 2006, 16 (04) : 305 - 317
  • [26] N-Glycans in cancer progression
    Lau, Ken S.
    Dennis, James W.
    GLYCOBIOLOGY, 2008, 18 (10) : 750 - 760
  • [27] Characterization of recombinant human lactoferrin N-glycans expressed in the milk of transgenic cows
    Le Parc, Annabelle
    Karav, Sercan
    Rouquie, Camille
    Maga, Elizabeth A.
    Bunyatratchata, Apichaya
    Barile, Daniela
    PLOS ONE, 2017, 12 (02):
  • [28] N-glycans of recombinant human acid α-glucosidase expressed in the milk of transgenic rabbits
    Jongen, Susanne P.
    Gerwig, Gerrit J.
    Leeflang, Bas R.
    Koles, Kate
    Mannesse, Maurice L. M.
    van Berkel, Patrick H. C.
    Pieper, Frank R.
    Kroos, Marian A.
    Reuser, Arnold J. J.
    Zhou, Qun
    Jin, Xiaoying
    Zhang, Kate
    Edmunds, Tim
    Kamerling, Johannis P.
    GLYCOBIOLOGY, 2007, 17 (06) : 600 - 619
  • [29] Synthetic Study of N-glycans
    Manabe, Yoshiyuki
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2018, 76 (05) : 502 - 505
  • [30] The role of N-glycans in spermatogenesis
    Fukuda, MN
    Akama, TO
    CYTOGENETIC AND GENOME RESEARCH, 2003, 103 (3-4) : 302 - 306